1.A Retrospective Study with Immunohistochemical Analysis of Axillary Nodal Micrometastasis in Breast Cancer .
Hyun Seog SO ; Suck Hwan KOH ; Yun Hwa KIM
Journal of Korean Breast Cancer Society 1999;2(2):240-250
PURPOSE: It is well established that the presence of axillary nodal metastases is the most important prognostic factor in primary operable breast cancer. However, it has also been shown that 15-30% of patients without lymph node metastases as assessed by light microscopy have recurrence within 10 years. In this study, our aim was first to investigate the diagnostic value of immunohistochemical staining in detecting micrometastases and secondly to correlate their presence with prognosis (recurrence and survival) MATERIALS AND METHODS: We retrospectively analyzed 492 axillary nodes from 49 consecutive node-negative invasive breast cancers treated at Kyung-Hee University Hospital from 1991 to 1995 with average follow-up of 60.2 (21-100) months. An additional section of original paraffin blocks was cut and stained by immunohistochemical chemical technique using monoclonal antibodies (AE 1/3 and No.7) to cytokeratin. RESULTS: Micrometastases with individual cell and cell clusters were readily detected by this technique in 27% of the cases. These were no predictors of micrometastses among the clinicopathological data of patient. The presence of micometastases wes not associated with disease-free and overall survival but loco-regional recurrence rate. CONCLUSIONS: A combination of immunohistochemistry and serial sectioning of axillary lymph node would help evaluate the significance of occult axillary metastases. Patients with node-negative disease may relapse after many years and prolonged follow-up is required to establish the role of mirometastases. Such an approach, together with a search for bone marrow micrometastases and epidemiologic, clinical, pathologic and/or biochemical prognostic factors, may serve to identify high risk patients in the presumed node-negative group. It would provide a rational basis for the selective use of adjuvant therapy.
Antibodies, Monoclonal
;
Bone Marrow
;
Breast Neoplasms*
;
Breast*
;
Follow-Up Studies
;
Humans
;
Immunohistochemistry
;
Keratins
;
Lymph Nodes
;
Microscopy
;
Neoplasm Metastasis
;
Neoplasm Micrometastasis*
;
Paraffin
;
Prognosis
;
Recurrence
;
Retrospective Studies*
2.Metabolic studies of skin flaps of rats using NMR spectroscopy.
Kyung Suck KOH ; Choon Sin LEE ; Kun Chul YOON ; Robert S CHUNG ; Dae Gun LEE ; Tae Whan LEEM ; Yun LEE
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1992;19(3):382-389
No abstract available.
Animals
;
Magnetic Resonance Spectroscopy*
;
Rats*
;
Skin*
3.The Role of Tumor Necrosis Factor-alpha and Interleukin-1beta as Predictable Markers for Development of Adult Respiratory Distress Syndrome in Septic Syndrome.
Youn Suck KOH ; Yun Hae JANG ; Woo Sung KIM ; Won Dong KIM ; Jae Dam LEE ; Soon Hwan OH
Tuberculosis and Respiratory Diseases 1994;41(5):452-461
BACKGROUND: Tumor necrosis factor(TNF)-alpha and Interleukin(IL)-1beta are thought to play a major role in the pathogenesis of the septic syndrome, which is frequently associated with adult respiratory distress syndrome(ARDS). In spite of many reports for the role of TNF-alpha in the pathogenesis of ARDS, including human studies, it has been reported that TNF-alpha is not sensitive and specific marker for impending ARDS. But there is a possibility that the results were affected by the diversity of pathogenetic mechanisms leading to the ARDS because of various underlying disorders of the study group in the previous reports. The purpose of the present study was to evaluate the roles of TNF-alpha and IL-lbeta as a predictable marker for development of ARDS in the patients with septic syndrome, in which the pathogenesis is believed to be mainly cytokine-mediated. METHODS: Thirty-six patients of the septic syndrome hospitalized in the intensive care units of the Asan Medical Center were studied. Sixteens suffered from ARDS, whereas the remaining 20 were at the risk of developing ARDS(acute hypoxemic respiratory failure, AHRF). In all patients venous blood sample were collected in heparin-coated tubes at the time of enrollment, at 24 and 72 h thereafter. TNF-alpha and IL-lbeta was measured by an enzyme-linked immunosorbent assay (ELISA). All data are expressed as median with interquartile range. RESULTS: 1) Plama TNF-alpha levels: Plasma TNF-beta levels were less than 10pg/mL, which is lowest detection value of the kit used in this study within the range of the mean+/-2SD, in all of the normal controls, 8 of 16 subjects of ARDS and in 8 in 20 subjects of AHRF. Plasma TNF-alpha levels from patients with ARDS were 10.26pg/mL(median;<10-16.99pg/mL, interquartile range) and not different from those of patients at AHRF(10.82, <10-20.38pg/mL). There was also no significant difference between pre-ARDS(<10, <10-15.32pg/mL) and ARDS(<10, <10-10.22pg/mL). TNF-alpha levels were significantly greater in the patients with shock than the patients without shock(12.53pg/mL vs. <10pg/mL) (P<0.01). There was no statistical significance between survivors(< 10, <10-12.92pg/mL) and nonsurvivors(11.80, <10-20.8pg/mL) (P=0.28) in the plasma TNF-alpha levels. 2) Plasma IL-lbeta levels: Plasma IL-1beta levels were less than 0.3ng/mL, which is the lowest detection value of the kit used in this study, in one of each patients group. There was no significant difference in IL-1beta levels of the ARDS(2.22, 1.37-8.01ng/mL) and of the AHRF(2.13, 0.83-5.29ng/mL). There was also no significant difference between pre-ARDS(2.53, <0.3-8.34ng/mL) and ARDS(5.35, 0.66-11.51ng/mL), and between patients with septic shock and patients without shock (2.51, 1.28-8.34 vs 1.46, 0.15-2.13ng/mL). Plasma IL-19 levels were significantly different between survivors(1.37, 0.4-2.36ng/mL) and nonsurvivors(2.84, 1.46-8.34ng/mL). CONCLUSION: Plasma TNF-alpha and IL-1beta level are not a predictable marker for development of ARDS. But TNF-alpha is a marker for shock in septic syndrome. These result could not exclude a possibility of pathophysiologic roles of TNF-alpha and IL-1beta in acute lung injury because these cytokine could be locally produced and exert its effects within the lungs.
Acute Lung Injury
;
Adult*
;
Chungcheongnam-do
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Intensive Care Units
;
Interleukin-1beta*
;
Lung
;
Lymphotoxin-alpha
;
Necrosis
;
Plasma
;
Respiratory Distress Syndrome, Adult*
;
Respiratory Insufficiency
;
Shock
;
Shock, Septic
;
Tumor Necrosis Factor-alpha*
4.Radionuclide Evaluation of Left and Right Ventricular Function with Intravenous Verapamil Administration in Essential Hypertension.
Ho Ju YUN ; Youn Suck KOH ; Jung Hyun KIM ; Heon Kil LIM ; Bang Hun LEE ; Chung Kyun LEE
Korean Circulation Journal 1988;18(2):199-206
The effects of intravenous Verapamil administration on ventricular function were evaluated using grated radionuclide ventriculography in 15 patients with essential hypertension. Verapamil(0.1mg/kg) was injected as a bolus for 2 minutes followed by an infusion of 0.007mg/kg/min. Heart rate, blood pressure, ejection fraction, peak ejection rate, total filling time, and prak filling rate were assessed before and after Verapamil administration. The results were was as follows ; 1) Verapamil administration increased heart rate from 63+/-5 to 75+/-9 beats/min(p<0.01) and reduced systolic and diastolic blood pressure from 156+/-17/99+/-6mmHg to 139+/-16/88+/-6mmHg(p<0.01). 2) Ejection fraction, peak ejection rate, and total filling time were not changed significantly after Verapamil injection. 3) Right and left ventricular peak filling rate increased significantly only in patients in whom it was subnormal in the basal study) from 1.6+/-0.4 to 2.3+/-1.1 end-diastolic volumes/s, p<0.05 and from 2.5+/-0.6 to 3.1+/-0.8 end-diastolic volumes/s, p<0.05, respectively). In conclusion, it was found that intravenous Verapamil administration enhances ventricular diatolic function in patients with essential hypertension.
Blood Pressure
;
Heart Rate
;
Humans
;
Hypertension*
;
Radionuclide Ventriculography
;
Ventricular Function
;
Ventricular Function, Right*
;
Verapamil*
5.A Case of Superior Vena Cava Syndrome Caused by Klebsiella Pneumonia.
Ju Young KIM ; Chae Man LIM ; Seon Hee KIM ; Yun Ho CHU ; Youn Suck KOH ; Woo Sung KIM ; Won Dong KIM
Tuberculosis and Respiratory Diseases 1994;41(1):58-62
Superior vents lava(SVC) syndrome is mostly related to a malignant process, but many different benign causes haute also been described. We report a case of SVC syndrome caused by Klebsiella pneumonia diagnosed by sputum culture and serial chest X-ray changes. A 27-year-old man had been in stable health until three days before admission, when he complained of pleuritic chest pain, facial flushing, and shortness of breath. Examination of the head and neck disclosed edema of face and both arms, and jugular venous distention to the angle of the jaw. The chest auscultation resealed decreased breath sound without crackle on right upper lung field. The chest roentgenogram showed homogenous air space consolidation on right upper lobe, asociated with downward displacement of minor fissure and contralateral displacement of trachea, but air bronchogram was not seen. We began antibiotic therapy under impression of pneumonia after assailable culture was taken from blood and sputum. SVC scintigraphy showed stasis of drain of right brachiocephalic vein at the proximal portion with reflux into the right internal jugular vein and faintly visible SVC via the collaterals. Sputum culture resealed Klebsiella pneumoniae. Antibiotic therapy resulted in a cure of infection and disappearance of facial swelling. Follow-up SVC scintigraphy after 20 days showed normal finding. We first report a case of SVC syndrome caused by klebsiella pneumonia
Adult
;
Arm
;
Auscultation
;
Brachiocephalic Veins
;
Chest Pain
;
Dyspnea
;
Edema
;
Flushing
;
Follow-Up Studies
;
Head
;
Humans
;
Jaw
;
Jugular Veins
;
Klebsiella pneumoniae
;
Klebsiella*
;
Lung
;
Neck
;
Pneumonia*
;
Radionuclide Imaging
;
Respiratory Sounds
;
Sputum
;
Superior Vena Cava Syndrome*
;
Thorax
;
Trachea
;
Vena Cava, Superior*
6.Cardiovascular Risk Assessment of Atherosclerotic Arterial Occlusive Diseases.
Ho Yeun KIM ; Sun Jin PARK ; Jung Yun SONG ; Suck Hwan KOH ; Sung Hwa HONG ; Su Myung OH ; Ho Chul PARK
Journal of the Korean Society for Vascular Surgery 2007;23(1):6-10
PURPOSE: Cardiovascular risk assessment of atherosclerotic arterial occlusive diseases is a critical component of preoperative care. Many indexes have been developed to help identify patients at high risk for perioperative cardiac events. We sought to study guideline implementation and clinical outcomes in cardiovascular risk assessment. METHOD: We studied 75 patients who underwent preoperative cardiac risk assessment between 2003 and 2006 at the Kyung Hee University Medical Center. The American College of Cardiology/American Heart Association (ACC/AHA) guidelines were used to stratify the patients. RESULT: The mean age of patients was 67.9 years. When stratified into risk categories according to the ACC/AHA guidelines, 2 patients was high risk group, 51 intermediate risk group, and 22 low risk group. There were 3 perioperative cardiac complications (4.0%) including 2 mortalities (2.7%). There was a trend toward a higher frequency of cardiac complications when there was discordance with the ACC/AHA guidelines, but there was no significant difference (discordance 7.1%, concordance 0%, P=0.251). The guidelines recommended cardiac testing for 44 patients, but 12 patients (27.3%) were tested. The guidelines did not recommend for 31 patients, but additional cardiac tests were done for 10 patients (32.3%) and mainly associated with low risk group. CONCLUSION: Differences between clinician practice and guideline recommendations existed and did not result in a higher frequency of cardiac complications.
Academic Medical Centers
;
Arterial Occlusive Diseases*
;
Heart
;
Humans
;
Mortality
;
Preoperative Care
;
Risk Assessment*
7.Study on the Clonality of Endothelial Cell Proliferation in Plexiform Lesions in Patients with Pulmonary Hypertension Associated with CREST Syndrome.
Sang Do LEE ; Yong Gam JEON ; Ji Hyun LEE ; Tae Sun SHIM ; Chae Man LIM ; Yun Suck KOH ; Woo Sung KIM ; Dong Soon KIM ; Won Dong KIM ; Rubin M TUDER
Tuberculosis and Respiratory Diseases 1999;47(2):150-160
BACKGROUND: The CREST syndrome is an indolent form of progressive systemic sclerosis. Although its clinical progress is indolent, pulmonary hypertension(PH) associated with CREST syndrome have grave prognosis with over 40 percent mortality rate at 2 year follow-up. But the pathogenesis of pulmonary hypertension in this disease is not known, and classified as either primary or secondary PH. Clonality of endothelial cell proliferation in plexiform lesion is a molecular marker which allows distinction between primary and secondary PH. We performed this study to know whether the PH associated with CREST syndrome is a variant of primary PH or is a secondary PH. METHODS: We assessed the X-chromosome inactivation based on the methylation pattern of the human androgen-receptor gene by PCR(HUMARA). Endothelial cells in plexiform lesions from female patients(n=3) with PH associated with CREST syndrome were microdissected from paraffin blocks. Vascular smooth muscle cells and lung parenchyma were also microdissected for clonality studies. RESULTS: The proliferating endothelial cells in 14 plexiform lesions were all polyclonal. Similarly proliferated smooth muscle cells from 5 vessels with medial hypertrophy were also polyclonal. CONCLUSION: These results suggest that the pulmonary hypertension associated with CREST syndrome has different pathogenesis from primary PH and to be classified as secondary PH.
CREST Syndrome*
;
Endothelial Cells*
;
Female
;
Follow-Up Studies
;
Humans
;
Hydrogen-Ion Concentration
;
Hypertension, Pulmonary*
;
Hypertrophy
;
Lung
;
Methylation
;
Mortality
;
Muscle, Smooth, Vascular
;
Myocytes, Smooth Muscle
;
Paraffin
;
Prognosis
;
Scleroderma, Diffuse